Revenue: The sum of all revenue fields included for a company's operating activities.
Denali Therapeutics Inc. (DNLI) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-132.97M |
|
-- |
|
-- |
|
$145.58M |
|
$-145.58M |
|
$12.61M |
|
$-132.97M |
|
$-132.97M |
|
$-132.97M |
|
$-132.97M |
|
$-132.97M |
|
$-132.97M |
|
$-145.58M |
|
$-147.14M |
|
171.22M |
|
171.22M |
|
$-0.78 |
|
$-0.78 |
|
| Balance Sheet Financials | |
$878.64M |
|
$57.77M |
|
$392.70M |
|
$1.27B |
|
$91.88M |
|
$5.60M |
|
$56.78M |
|
$148.66M |
|
$1.12B |
|
$1.12B |
|
$1.12B |
|
145.25M |
|
| Cash Flow Statement Financials | |
$-131.47M |
|
$18.75M |
|
$-3.76M |
|
$176.53M |
|
$60.05M |
|
$-116.48M |
|
$25.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.56 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-136.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.84% |
|
-11.84% |
|
-10.46% |
|
-11.79% |
|
$7.73 |
|
$-0.80 |
|
$-0.77 |
|